Adjusted earnings will be $12.12 to $12.32 a share in 2025, North Chicago ... a schizophrenia drug Abbvie acquired in its $8.7 billion buyout of Cerevel Therapeutics Inc. failed in clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback